The genetic signature of diabetes mellitus-from glucagon-like peptide-1 (GLP-1) treatment to diagnosis
博士 === 長庚大學 === 臨床醫學研究所 === 104 === Type 2 diabetes patients have been proved to have decreased glucagon-like peptide-1 (GLP-1) levels. GLP-1 analogue therapy is associated with improved glycemic control by boosting GLP-1 levels. Nevertheless, the clinical effects are in great diversity for poorly c...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2016
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/t476q6 |